Table 2. Metabolic characteristics of the study population.

	PsA (n = 40)
Fasting glucose, mg/dL	95.1 ± 14.9
• 30 min glucose, mg/dL	159.4 ± 40.2
• 60 min glucose, mg/dL	156.2 ± 45.1
• 90 min glucose, mg/dL	139.1 ± 48.5
• 120 min glucose, mg/dL	117.0 (98.7–131.3)
Fasting insulin, μUI/mL	11.7 (7.0 18.3)
• 30 min insulin, μUI/mL	102.9 ± 75.1
• 60 min insulin, μUI/mL	119.0 ± 68.8
• 90 min insulin, μUI/mL	115.5 ± 81.2
• 120 min insulin, μUI/mL	69.5 (43.0–126.5)
Insulin Sensitivity Index (ISI) ISI ≤ 2.5	3.5 ± 2.5 18(45)
Insulinogenic Index (IGI)	1.2 (0.7–1.8)
Oral disposition Index (ODI)	4.5 ± 4.5
Normal Glucose Tolerance (NGT), n (%)	24 (52.5)
Impaired Fasting Glucose (IFG), n (%)	8 (20)
Impaired Glucose Tolerance (IGT), n (%)	3 (7.5)
IFG plus IGT, n (%)	1 (2.5)
Type 2 Diabetes, n (%)	4 (10)

Legend: PsA, psoriatic arthritis.